Posted by Michael Wonder on 24 Jun 2023
FDA approves Pfizer’s Litfulo (ritlecitinib) for adults and adolescents with severe alopecia areata
23 June 2023 - Litfulo is the first and only treatment for severe alopecia areata approved for patients as young as 12.
Pfizer announced today that the US FDA has approved Litfulo (ritlecitinib), a once daily oral treatment, for individuals 12 years of age and older with severe alopecia areata.
